Unknown

Dataset Information

Personalized health care beyond oncology: new indications for immunoassay-based companion diagnostics.


ABSTRACT: Personalized health care (PHC) is an evolving field of medicine aimed at providing the right therapy to the right patient at the right time. This approach often incorporates the use of companion diagnostics (CDx) assays that provide information essential for the safe and effective use of the corresponding drug. In addition to oncology, many other therapy areas, such as cardiovascular, neurological, and infectious and inflammatory diseases, may benefit from PHC, owing to disease complexity and heterogeneity. Furthermore, although most U.S. Food and Drug Administration-approved CDx are based on molecular-based technologies, immunoassays can provide a significant contribution to the evolution of CDx in patient management. In this review we discuss how the incorporation of biomarker immunoassa

SUBMITTER: Batrla R 

PROVIDER: S-EPMC4744740 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature